KR880009661A - 궤양성 대장염치료를 위한 사람의 혈액응고인자 xiii의 용도 - Google Patents

궤양성 대장염치료를 위한 사람의 혈액응고인자 xiii의 용도 Download PDF

Info

Publication number
KR880009661A
KR880009661A KR1019880001129A KR880001129A KR880009661A KR 880009661 A KR880009661 A KR 880009661A KR 1019880001129 A KR1019880001129 A KR 1019880001129A KR 880001129 A KR880001129 A KR 880001129A KR 880009661 A KR880009661 A KR 880009661A
Authority
KR
South Korea
Prior art keywords
treatment
factor xiii
ulcerative colitis
blood coagulation
coagulation factor
Prior art date
Application number
KR1019880001129A
Other languages
English (en)
Other versions
KR960014789B1 (en
Inventor
미끼오 우라베
사또시 다나까
게니찌로 쯔무라
Original Assignee
호스트 웨스체
훽스트 저펜 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12192122&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR880009661(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 호스트 웨스체, 훽스트 저펜 리미티드 filed Critical 호스트 웨스체
Publication of KR880009661A publication Critical patent/KR880009661A/ko
Application granted granted Critical
Publication of KR960014789B1 publication Critical patent/KR960014789B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)

Abstract

내용 없음.

Description

궤양성 대장염치료를 위한 사람의 혈액응고인자 XIII의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 궤양성 대장염을 치료하는 약제학적 조성물을 제조하기 위한 사람의 혈액응고인자 XIII의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR88001129A 1987-02-09 1988-02-08 Composition of human blood coagulation factor ñ˜ñ for thr treatment of ulcerative colitis KR960014789B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62026387A JPS63196520A (ja) 1987-02-09 1987-02-09 潰瘍性大腸炎治療剤
JP?62-26387 1987-02-09

Publications (2)

Publication Number Publication Date
KR880009661A true KR880009661A (ko) 1988-10-04
KR960014789B1 KR960014789B1 (en) 1996-10-19

Family

ID=12192122

Family Applications (1)

Application Number Title Priority Date Filing Date
KR88001129A KR960014789B1 (en) 1987-02-09 1988-02-08 Composition of human blood coagulation factor ñ˜ñ for thr treatment of ulcerative colitis

Country Status (16)

Country Link
US (1) US5378687A (ko)
EP (1) EP0278416B1 (ko)
JP (1) JPS63196520A (ko)
KR (1) KR960014789B1 (ko)
AT (1) ATE83665T1 (ko)
AU (1) AU615428B2 (ko)
CA (1) CA1322161C (ko)
DE (1) DE3876817T2 (ko)
DK (1) DK63488A (ko)
ES (1) ES2052614T3 (ko)
GR (1) GR3007331T3 (ko)
HU (1) HU200277B (ko)
IE (1) IE61713B1 (ko)
IL (1) IL85346A (ko)
PT (1) PT86721B (ko)
ZA (1) ZA88852B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
JPH03240738A (ja) * 1990-02-20 1991-10-28 Hoechst Japan Ltd 糖尿病性壊疽治療剤
JPH07502734A (ja) * 1991-12-31 1995-03-23 ザイモジェネティクス，インコーポレイティド 血液損失を減少する方法および組成物
AU3428493A (en) * 1991-12-31 1993-07-28 Zymogenetics Inc. Novel human transglutaminases
AU2002360269B2 (en) * 2001-10-09 2007-03-22 Zymogenetics, Inc. Method for inhibiting the formation of seromas using factor XIII
US20060104946A1 (en) * 2002-08-23 2006-05-18 Zymogenetics, Inc. Method for treating inflammatory bowel disease
AU2005308830B2 (en) 2004-11-23 2012-01-19 Zymogenetics, Inc. Purification of recombinant human factor XIII
US20140286927A1 (en) * 2012-06-19 2014-09-25 Peter Edward Smith Method for the treatment of ulcerative colitis in patients refractory to steroid therapy using leached ligand fibrin stabilizing composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6029687B2 (ja) * 1978-11-07 1985-07-12 株式会社ミドリ十字 ヒト胎盤由来血液凝固第１０３因子の濃縮液の製造方法

Also Published As

Publication number Publication date
DK63488A (da) 1988-08-10
DK63488D0 (da) 1988-02-08
EP0278416A2 (en) 1988-08-17
KR960014789B1 (en) 1996-10-19
GR3007331T3 (ko) 1993-07-30
JPH0437049B2 (ko) 1992-06-18
PT86721B (pt) 1992-05-29
ZA88852B (en) 1988-11-30
JPS63196520A (ja) 1988-08-15
IL85346A0 (en) 1988-07-31
DE3876817T2 (de) 1993-05-19
HU200277B (en) 1990-05-28
PT86721A (pt) 1988-03-01
ES2052614T3 (es) 1994-07-16
EP0278416A3 (en) 1990-07-11
IE61713B1 (en) 1994-11-30
CA1322161C (en) 1993-09-14
AU1138288A (en) 1988-08-11
AU615428B2 (en) 1991-10-03
HUT47221A (en) 1989-02-28
ATE83665T1 (de) 1993-01-15
IE880334L (en) 1988-08-09
IL85346A (en) 1992-07-15
DE3876817D1 (de) 1993-02-04
US5378687A (en) 1995-01-03
EP0278416B1 (en) 1992-12-23

Similar Documents

Publication Publication Date Title
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
NO951592L (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
KR890011606A (ko) 항응고제
KR900009079A (ko) 비스(3,5-디-tert-부틸-4-히드록시페닐티오)메탄 함유 콜레스테롤 저하제겸 아테롬성 동맥 경화증 치료제
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
ES2040106T3 (es) Utilizacion de la acetil d-carnitina en el tratamiento terapeutico del glaucoma.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
KR950701820A (ko) 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders)
KR880009661A (ko) 궤양성 대장염치료를 위한 사람의 혈액응고인자 xiii의 용도
KR890700026A (ko) 건선 치료에 있어서 주석 프로토포르피린 및 주석 메조포르피린의 용도
KR890000097A (ko) 항레트로비루스 작용을 갖는 당단백질 처리 억제제
ATE83378T1 (de) Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen.
KR890012659A (ko) 조산아의 뇌실내 출혈방지용 치료제
KR900002802A (ko) 면역억제제로서의 트랜스글루타미나제의 용도
ATE7107T1 (de) Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln.
KR910005850A (ko) 피부 외용제
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
KR890003374A (ko) 정신 분열증 치료용 약제의 제조에 2-아미노-6-(트리플루오로메톡시)벤조티아졸의 이용
FI891011A0 (fi) Foerfarande foer katalytisk oxidering av alkaner i alkohol- och ketonblandningar.
KR890003373A (ko) 수면장애 및 우울증 치료에 화합물의 이용
ES2061007T3 (es) Preparacion farmaceutica que contiene proteina-s.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
ATE137955T1 (de) Verwendung von 1,2-dipalmitoyl-l-alpha- phosphatidyl-n,n-dimethylethanilamine in dermatologischen und kosmetischen zusammensetzungen
ATE70440T1 (de) Verwendung von anipamil als artereosklerosemittel.
KR900012622A (ko) 피부질환치료 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20101012

Year of fee payment: 15

EXPY Expiration of term